As Vice President at EdiGene, Feifei leads cell therapy process development and manufacturing. With over 10 years of experience in immunology, she specializes in advancing CAR-T products from pre-clinical to clinical stages. She holds a PhD in Cellular and Molecular Biology from Paris-Sud University.
Her expertise is centered on the critical process of translating cell therapies from early-stage laboratory research into human clinical trials.
Feifei L.
Senior Scientist at Legend Biotech
Beijing, China
Overview
Topics They Care About
Cell Therapy Manufacturing
As VP and Head of Cell Therapy Process Development & Manufacturing at EdiGene, this is her primary area of professional responsibility and expertise.
CAR-T Process Development
Her experience at both EdiGene and Legend Biotech involved hands-on leadership in developing CAR-T product processes from the pre-clinical phase to clinical trials.
Clinical Translation
A recurring theme in her career is moving therapies from the lab to the clinic, bridging the gap between early research and patient application.
Media Appearances
Feifei has no verified media appearances
Work History
9-2019 - 9-2021
Senior Scientist at Legend Biotech
10-2014 - 9-2021
Research Scientist at Svar Life Science AB (formerly Euro Diagnostica AB)
2011 - 9-2014
Post doc at LBPA ENS cachan
博雅辑因 at Permanent
Education
2007 - 2011
博士 from Paris-Sud University (Paris XI)
2006 - 2007
Master's degree from Pierre and Marie Curie University
More Information
Social Presence :
Prographics :
Exp : 10
Location : Beijing, China
Job Level : N/A
Designation : Senior Scientist at Legend Biotech
